Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02808468 · ClinicalTrials.gov registry record · NA

Brief Restructuring Intervention Following Trauma Exposure

A NA study of Post Traumatic Stress Disorder and Alcohol Use Disorders, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
57
Enrollment target
1
Study location

NCT02808468: Completed NA study of Post Traumatic Stress Disorder and Alcohol Use Disorders, sponsored by University of Washington.

NCT02808468 is a NA study of Post Traumatic Stress Disorder and Alcohol Use Disorders that has completed, run by University of Washington. The registered enrollment target is 57 participants, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02808468, a NA study of Post Traumatic Stress Disorder and Alcohol Use Disorders, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
57 participants
Enrollment target
1
Study location

Study Summary

The broad aim of this study is to develop and test a brief intervention that can be implemented in the immediate weeks following sexual assault to decrease likelihood of developing posttraumatic stress disorder (PTSD) or alcohol misuse. The first phase of the study will enroll 6 women to complete a brief, cognitive therapy protocol and provide feedback on the intervention (open trial). The second phase of the study will recruit 76 women to complete either the intervention (38 women) or assessment only (38 women) to test the effects of the intervention on both PTSD symptoms and alcohol use behavior as compared to natural recovery following assault.

Primary Outcome

The Posttraumatic Stress Disorder Symptom Scale- Interview Version (PSS-I) assesses severity of symptoms of posttraumatic stress disorder (PTSD) as defined by the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) and is administered at baseline and 3 month follow up to assess change in PTSD symptoms. The range for the scale is 0-80 with higher scores representing more severe PTSD symptoms.

Conditions Studied

Post Traumatic Stress Disorder Alcohol Use Disorders

Interventions

  • BEHAVIORAL Brief Cognitive Therapy

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2015-03-01
Est. Completion 2020-02
Phase NA
University of Washington

1,048 total trials

What the finished NCT02808468 record still lists

NCT02808468 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (91% lower).

The record links to 2 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which Brief Cognitive Therapy is the first listed.

NCT02808468 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT02808468 about?

NCT02808468 is a clinical study titled "Brief Restructuring Intervention Following Trauma Exposure". The broad aim of this study is to develop and test a brief intervention that can be implemented in the immediate weeks following sexual assault to decrease likelihood of developing posttraumatic stress disorder (PTSD) or alcohol misuse. The first phase of the study will enroll 6 women to complete a ...

What is the current status of trial NCT02808468?

This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2015-03-01. Estimated completion is 2020-02.

What conditions does trial NCT02808468 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Alcohol Use Disorders.

What interventions are being tested in trial NCT02808468?

The interventions under investigation include: Brief Cognitive Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT02808468?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02808468 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02808468's enrollment target sits among peer trials

57 169th of 262 higher than 93 of 262 other Post Traumatic Stress Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03521830 · 57 participants · Phase 2

    Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

  • NCT03587701 · 57 participants · Phase 2

    Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease

  • NCT04104126 · 57 participants · NA

    Blood Flow Restriction Therapy in Achilles Injury

  • NCT04703842 · 57 participants · Phase 1

    Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT02808468, the US trial registry maintained by the National Library of Medicine. NCT02808468 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.